CoChat

Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment

Open access
Oca, Ana I., Pérez-Sala, Álvaro, Pariente, Ana, Ochoa, Rodrigo, Velilla, Sara, Peláez, Rafael, Larráyoz, Ignacio M. · 2021 · Journal of Personalized Medicine

The DOI matches its Crossref record; 78 of the 82 references it cites were found in a registry or an index.

Abstract

Age-related macular degeneration (AMD) is an incurable disease associated with aging that destroys sharp and central vision. Increasing evidence implicates both systemic and local inflammation in the pathogenesis of AMD. Intravitreal injection of anti-vascular endothelial growth factor (VEGF) agents is currently the first-line therapy for choroidal neovascularization in AMD patients. However, a high number of patients do not show satisfactory responses to anti-VEGF treatment after three injections. Predictive treatment response models are one of the most powerful tools for personalized medicine. Therefore, the application of these models is very helpful to predict the optimal treatment for an early application on each patient. We analyzed the transcriptome of peripheral blood mononuclear cells (PBMCs) from AMD patients before treatment to identify biomarkers of response to ranibizumab. A classification model comprised of four mRNAs and one miRNA isolated from PBMCs was able to predict the response to ranibizumab with high accuracy (Area Under the Curve of the Receiver Operating Characteristic curve = 0.968), before treatment. We consider that our classification model, based on mRNA and miRNA from PBMCs allows a robust prediction of patients with insufficient response to anti-VEGF treatment. In addition, it could be used in combination with other methods, such as specific baseline characteristics, to identify patients with poor response to anti-VEGF treatment to establish patient-specific treatment plans at the first visit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jpm11121329

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Classification model performance from informative mRNA data. A ROC was constructed with expression data from 10 mRNAs (ENSG00000249572, ENSG00000176531, ENSG00000240350, ENSG00000161298, ENSG00000049239, ENSG00000226479, ENSG00000198056, ENSG00000104450, ENSG00000156510, and ENSG00000158106) from the 59 patients. The classification model was built using a Random Forest classifier optimized by the meta classifier Random Committee, included in the WEKA suite. AUC = Area under the curve.
Figure 1 Classification model performance from informative mRNA data. A ROC was constructed with expression data from 10 mRNAs (ENSG00000249572, ENSG00000176531, ENSG00000240350, ENSG00000161298, ENSG00000049239, ENSG00000226479, ENSG00000198056, ENSG00000104450, ENSG00000156510, and ENSG00000158106) from the 59 patients. The classification model was built using a Random Forest classifier optimized by the meta classifier Random Committee, included in the WEKA suite. AUC = Area under the curve.CC BY · PubMed Central
Figure 2 Classification model performance from informative miRNA data. A ROC was constructed with expression data from 18 miRNAs (hsa-miR-1284, hsa-miR-185-5p, hsa-miR-20a-5p, hsa-miR-210-5p, hsa-miR-3127-5p, hsa-miR-3149, hsa-miR-34c-5p, hsa-miR-511-5p, hsa-miR-548ah-3p, hsa-miR-551b-5p, hsa-miR-579-3p, hsa-miR-615-5p, hsa-miR-6786-3p, hsa-miR-6798-3p, hsa-miR-6813-5p, hsa-miR-6850-3p, hsa-miR-6875-5p and hsa-miR-6889-5p) from the 59 patients. The classification model was built using a SMO-based classifier, included in the WEKA suite. AUC = Area under the curve.
Figure 2 Classification model performance from informative miRNA data. A ROC was constructed with expression data from 18 miRNAs (hsa-miR-1284, hsa-miR-185-5p, hsa-miR-20a-5p, hsa-miR-210-5p, hsa-miR-3127-5p, hsa-miR-3149, hsa-miR-34c-5p, hsa-miR-511-5p, hsa-miR-548ah-3p, hsa-miR-551b-5p, hsa-miR-579-3p, hsa-miR-615-5p, hsa-miR-6786-3p, hsa-miR-6798-3p, hsa-miR-6813-5p, hsa-miR-6850-3p, hsa-miR-6875-5p and hsa-miR-6889-5p) from the 59 patients. The classification model was built using a SMO-based classifier, included in the WEKA suite. AUC = Area under the curve.CC BY · PubMed Central
Figure 3 Classification model performance from informative mRNA and miRNA data. A ROC was constructed with expression data from mRNAs (ENSG00000249572, ENSG00000161298, ENSG00000226479 and ENSG00000198056) and 1 miRNAs (hsa-miR-20a-5p) from the 59 patients. The classification model was built using a Naïve Bayes classifier, included in the WEKA suite. AUC = Area under the curve.
Figure 3 Classification model performance from informative mRNA and miRNA data. A ROC was constructed with expression data from mRNAs (ENSG00000249572, ENSG00000161298, ENSG00000226479 and ENSG00000198056) and 1 miRNAs (hsa-miR-20a-5p) from the 59 patients. The classification model was built using a Naïve Bayes classifier, included in the WEKA suite. AUC = Area under the curve.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 78 references

Cited by

See all 25

Metadata

Authors
Oca, A. I., Pérez-Sala, Á., Pariente, A., Ochoa, R., Velilla, S., Peláez, R., & Larráyoz, I. M.
Affiliations
  • Biomarkers and Molecular Signaling Group, Center for Biomedical Research of La Rioja (CIBIR), Foundation Rioja Salud, 26006 Logroño, La Rioja, Spain
  • Center for Biomedical Research of La Rioja (ES)
  • Universidad de La Rioja (ES)
Corresponding author
Larráyoz, Ignacio M.
Venue
Journal of Personalized Medicine
Publisher
MDPI AG
Published
2021-12-08
Volume
11
Issue
12
Pages
1329
ISSN
2075-4426 (ISSN-L)
OpenAlex
W4200024873
Cited by
25
References
82
Citations by year
2026: 3 · 2025: 8 · 2024: 2 · 2023: 6 · 2022: 6
FWCI
3.14
Type
journal article
Language
en
Open access
Locations
  • Journal of Personalized Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • RIUR (Universidad de La Rioja) (submittedVersion, other-oa)
Funders
Instituto de Salud Carlos III (PI19/01805, CPII20/00029)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
age-related macular degeneration, anti-VEGF therapy, ranibizumab, predictive biomarkers, treatment response prediction, peripheral blood mononuclear cells, transcriptome, mRNA biomarkers, microRNA biomarkers, choroidal neovascularization, personalized medicine, inflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment. https://app.cochat.ai/papers/10.3390/jpm11121329
The paper
Oca, A. I., Pérez-Sala, Á., Pariente, A., Ochoa, R., Velilla, S., Peláez, R., & Larráyoz, I. M. (2021). Predictive Biomarkers of Age-Related Macular Degeneration Response to Anti-VEGF Treatment. Journal of Personalized Medicine. https://doi.org/10.3390/jpm11121329

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.